Is a newly announced cancer therapy touted as "unprecedented" as game-changing as it's said to be? It's simply too soon to tell. At the annual meeting of the American Association for the Advancement of Science on Sunday, Stanley Riddell, an immunotherapy researcher and oncologist at Seattle's Fred Hutchinson Cancer Research Center, announced an exciting potential treatment.
Read Full Article »
